[go: up one dir, main page]

DE60127935D1 - Verfahren zur diagnose der effektivität der xenotypischen antikörpertherapie - Google Patents

Verfahren zur diagnose der effektivität der xenotypischen antikörpertherapie

Info

Publication number
DE60127935D1
DE60127935D1 DE60127935T DE60127935T DE60127935D1 DE 60127935 D1 DE60127935 D1 DE 60127935D1 DE 60127935 T DE60127935 T DE 60127935T DE 60127935 T DE60127935 T DE 60127935T DE 60127935 D1 DE60127935 D1 DE 60127935D1
Authority
DE
Germany
Prior art keywords
antibody
patient
xenotypic
xenotypic antibody
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60127935T
Other languages
English (en)
Other versions
DE60127935T2 (de
Inventor
Antoine Noujaim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Altarex Medical Corp
Original Assignee
Altarex Medical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altarex Medical Corp filed Critical Altarex Medical Corp
Publication of DE60127935D1 publication Critical patent/DE60127935D1/de
Application granted granted Critical
Publication of DE60127935T2 publication Critical patent/DE60127935T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96455—Kallikrein (3.4.21.34; 3.4.21.35)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60127935T 2000-02-08 2001-02-08 Verfahren zur diagnose der effektivität der xenotypischen antikörpertherapie Expired - Fee Related DE60127935T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US18100800P 2000-02-08 2000-02-08
US181008P 2000-02-08
US20186800P 2000-05-04 2000-05-04
US201868P 2000-05-04
PCT/IB2001/000423 WO2001059452A2 (en) 2000-02-08 2001-02-08 Method for diagnosing efficacy of xenotypic antibody therapy

Publications (2)

Publication Number Publication Date
DE60127935D1 true DE60127935D1 (de) 2007-05-31
DE60127935T2 DE60127935T2 (de) 2008-01-17

Family

ID=26876809

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60127935T Expired - Fee Related DE60127935T2 (de) 2000-02-08 2001-02-08 Verfahren zur diagnose der effektivität der xenotypischen antikörpertherapie

Country Status (11)

Country Link
US (1) US20020022235A1 (de)
EP (1) EP1254374B1 (de)
JP (1) JP2003522774A (de)
AT (1) ATE360212T1 (de)
AU (2) AU4098201A (de)
CA (1) CA2399067A1 (de)
DE (1) DE60127935T2 (de)
DK (1) DK1254374T3 (de)
ES (1) ES2284624T3 (de)
PT (1) PT1254374E (de)
WO (1) WO2001059452A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060159688A1 (en) * 1996-05-15 2006-07-20 Ragupathy Madiyalakan Method for diagnosing efficacy of xenotypic antibody therapy
US8038994B2 (en) 1996-05-15 2011-10-18 Quest Pharmatech Inc. Combination therapy for treating disease
GB2397018B (en) * 2001-10-26 2006-05-31 Altarex Medical Corp Combination therapy for treating disease
US20050260208A1 (en) * 2002-04-11 2005-11-24 Altarex Medical Corp. Binding agents and their use in targeting tumor cells
AU2003286463A1 (en) * 2002-10-17 2004-05-04 Altarex Medical Corp. Therapeutic adjuvant

Also Published As

Publication number Publication date
EP1254374A2 (de) 2002-11-06
CA2399067A1 (en) 2001-08-16
DK1254374T3 (da) 2007-09-03
JP2003522774A (ja) 2003-07-29
ES2284624T3 (es) 2007-11-16
PT1254374E (pt) 2007-07-20
WO2001059452A2 (en) 2001-08-16
AU4098201A (en) 2001-08-20
AU2001240982B2 (en) 2006-05-04
WO2001059452A3 (en) 2002-07-18
DE60127935T2 (de) 2008-01-17
EP1254374B1 (de) 2007-04-18
ATE360212T1 (de) 2007-05-15
US20020022235A1 (en) 2002-02-21

Similar Documents

Publication Publication Date Title
DK0536275T3 (da) Tumorvækstinhibitorer udledt fra væv, fremgangsmåde til deres fremstilling samt anvendelse heraf
MY158262A (en) Diagnosis and treatments of cancers and other conditions
DE60329165D1 (de) Detektion und/oder beobachtung von synuclein-assoziierten krankheiten
EP1285271A4 (de) Diagnose, prophylaxe und behandlung von morbus crohn durch die verwendung des ompc antigens(04.12.03)
ATE349446T1 (de) Amyloid plaque aggregationshemmer und diagnostische bilderzeugungsmittel
ATE394658T1 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
BR9917218A (pt) Anticorpos monoclonais, antìgenos, e diagnósticoe terapia de doenças malignas
WO2001075454A3 (en) Diagnosis and treatment of alzheimer's disease
ATE419516T1 (de) Monoklonale antikörper und zelloberflächenantigene zum nachweis und zur behandlung von kleinzelligem lungenkrebs (sclc)
ATE480251T1 (de) Diagnose und behandlung von malignen neoplasmen
WO2002059604A8 (en) Diagnosis and treatment of multiple sclerosis
ATE406578T1 (de) Candida-nachweis
MY142283A (en) Diagnosis and treatment of cancers and other conditions
DE69333076D1 (de) Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis
NZ531712A (en) Reagents and methods for diagnosing, imaging and treating atherosclerotic disease
DE60336138D1 (de) Verfahren zur diagnostik von tuberkulose
DE69841322D1 (de) Hepatitis c rezeptorprotein cd81
DE60127935D1 (de) Verfahren zur diagnose der effektivität der xenotypischen antikörpertherapie
EP1532162A4 (de) Humanisierter anti-tag-72 cc49 zur diagnose und therapie humaner tumore
EP1744162A4 (de) Krebsdiagnose und behandlung unter verwendung eines anti-robo1-antikörpers
BR0007702A (pt) Método e kit de diagnóstico para diagnose de endometriose
ATE557277T1 (de) Verfahren zur diagnose von endometriose mittels tfpi-2 protein
EP1821104A3 (de) Verfahren zur Diagnose der Effizienz xenotypischer Antikörperbehandlung
ATE335502T1 (de) Verwendung von glukose-6-phosphate-isomerase und dagegen gerichteten antikörpern zur diagnose und therapeutischen behandlung von arthritis, und test von zur behandlung der arthritis wirksamen verbindungen
EP1780215A4 (de) Morbus-crohn-antikörperepitoppeptid und reagens zum testen auf morbus crohn

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee